<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; MedcoHealth Solutions Inc.</title>
	<atom:link href="http://www.stockbloghub.com/tag/medcohealth-solutions-inc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(CVS) Management Churn at CVS Caremark</title>
		<link>http://www.stockbloghub.com/2012/04/04/cvs-management-churn-at-cvs-caremark-analyst-blog/97427</link>
		<comments>http://www.stockbloghub.com/2012/04/04/cvs-management-churn-at-cvs-caremark-analyst-blog/97427#comments</comments>
		<pubDate>Wed, 04 Apr 2012 16:54:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAI]]></category>
		<category><![CDATA[AirTran Holdings Inc]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=97427</guid>
		<description><![CDATA[CVS Caremark Corporation (CVS) recently announced a change in top management. According to the company’s design, effective September 1, 2012, the present EVP and Chief Operating Officer of the Pharmacy Benefit Management (PBM) business, Jon Roberts will replace Per Lofberg, the President of the PBM business. However, Robert will continue to report to Lofberg who extended his employment agreement with the company till December 2013. September onwards, Lofberg will serve as the chairman of the PBM and look after the business strategies of PBM, new business development, client relationship management and retention and will directly report to Larry Merlo, the President and CEO of CVS Caremark. Rhode Island-based CVS Caremark is a combination of a PBM as well as retail drug chain. In terms of contractual arrangements with large plan ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/04/04/cvs-management-churn-at-cvs-caremark-analyst-blog/97427/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Healh Analyst Reiterates Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2012/03/22/mhs-medco-healh-analyst-reiterates-shares-at-neutral/96119</link>
		<comments>http://www.stockbloghub.com/2012/03/22/mhs-medco-healh-analyst-reiterates-shares-at-neutral/96119#comments</comments>
		<pubDate>Thu, 22 Mar 2012 16:04:15 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAI]]></category>
		<category><![CDATA[AirTran Holdings Inc]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=96119</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $74.00. During the fourth quarter of fiscal 2011, Medco reported adjusted EPS of $1.25, beating the Zacks Consensus Estimate of $1.17 and 26.3% higher than the year-ago level. Increased sales combined with 8.3% reduction in number of shares outstanding contributed to the bottom-line improvement during the quarter. Additionally, the introduction of generic Lipitor contributed $0.03 to the fourth quarter EPS. For the full year, adjusted EPS came in at $4.17, surpassing the Zacks Consensus Estimate of $4.10 and was up 17.5% year over year. In fiscal 2011, Medco’s top ten clients (based on revenues) contributed approximately 46% to net revenues. Besides, the largest client, UnitedHealth accounted for 17% of net revenues. However, in July 2011, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/22/mhs-medco-healh-analyst-reiterates-shares-at-neutral/96119/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Company News for March 12, 2012 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2012/03/13/esrx-company-news-for-march-12-2012-corporate-summary/94789</link>
		<comments>http://www.stockbloghub.com/2012/03/13/esrx-company-news-for-march-12-2012-corporate-summary/94789#comments</comments>
		<pubDate>Tue, 13 Mar 2012 18:35:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[QSFT]]></category>
		<category><![CDATA[Quest Software Inc]]></category>
		<category><![CDATA[SBUX]]></category>
		<category><![CDATA[Starbucks Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94789</guid>
		<description><![CDATA[•    Starbucks Corporation (NASDAQ:SBUX) launched the latest espresso brewer and announced that the company will be selling single-cup coffee machines •    According to reports, the Federal Trade Commission will not obstruct the merger of Express Scripts, Inc. (NASDAQ:ESRX) and MedcoHealth Solutions Inc (NYSE:MHS).  Following this development, these stocks gained 1.7% and 1.4%, respectively •    Shares of Quest Software, Inc. (NASDAQ:QSFT) jumped 24.1% following reports that Insight Venture Partners will acquire it for around $2 billion •    Zogenix, Inc. (NASDAQ:ZGNX) released lower-than-expected 2012 revenue guidance.  Consequently, its shares slumped 18.5% EXPRESS SCRIPTS (ESRX): Free Stock Analysis Report MEDCO HLTH SOL (MHS): Free Stock Analysis Report QUEST SOFTWARE (QSFT): Free Stock Analysis Report STARBUCKS CORP (SBUX): Free Stock Analysis Report ZOGENIX INC (ZGNX): Free Stock Analysis Report View original at: Zacks Investment ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/13/esrx-company-news-for-march-12-2012-corporate-summary/94789/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Remains Neutral</title>
		<link>http://www.stockbloghub.com/2012/03/02/cvs-cvs-caremark-remains-neutral/94056</link>
		<comments>http://www.stockbloghub.com/2012/03/02/cvs-cvs-caremark-remains-neutral/94056#comments</comments>
		<pubDate>Fri, 02 Mar 2012 14:43:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94056</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $46.00. CVS reported adjusted EPS of 89 cents in the fourth quarter of 2011 in line with the Zacks Consensus Estimate and 12.6% higher than the year-ago quarter. For the full year, adjusted EPS rose 4.5% (5.9% excluding 2010 tax benefit) to $2.80, also matching the Zacks Consensus Estimate. CVS is gradually witnessing strong performance in the field of Pharmacy Services. After a sluggish phase, the company has exhibited improved performance in this segment for the fourth consecutive quarter and has started off the 2012 selling season on a positive note. With 90% of the contract renewals scheduled for 2012 already complete at the end of fiscal 2011, CVS’s retention rate was as high ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/02/cvs-cvs-caremark-remains-neutral/94056/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Corporation Ordered by FTC to Settle Claims</title>
		<link>http://www.stockbloghub.com/2012/01/13/cvs-cvs-caremark-corporation-ordered-by-ftc-to-settle-claims/90162</link>
		<comments>http://www.stockbloghub.com/2012/01/13/cvs-cvs-caremark-corporation-ordered-by-ftc-to-settle-claims/90162#comments</comments>
		<pubDate>Fri, 13 Jan 2012 21:05:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=90162</guid>
		<description><![CDATA[Recently CVS Caremark Corporation (CVS) was asked by the Federal Trade Commission (FTC) to pay $5 million to settle all claims related to the company’s misrepresentation of prices of certain Medicare Part D prescription drugs at CVS Caremark and Walgreen (WAG)  pharmacies. The FTC alleged that from 2007 through November 2008, CVS Caremark’s subsidiary RxAmerica posted wrong prices on its website for prescription drugs including medications to treat epilepsy and symptoms of breast cancer. It also provided incorrect prices for posting to Plan Finder and third-party websites. The cases were extremely misleading for several seniors and disabled customers as the posted prices were 10 times below the actual prices of the drugs. This fake interpretation encouraged patients to opt for RxAmerica’s plans, which later pushed them into the &#8220;doughnut hole” ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/13/cvs-cvs-caremark-corporation-ordered-by-ftc-to-settle-claims/90162/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreens 2012 First Quarter Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2012/01/09/wag-walgreens-2012-first-quarter-earnings-scorecard/89426</link>
		<comments>http://www.stockbloghub.com/2012/01/09/wag-walgreens-2012-first-quarter-earnings-scorecard/89426#comments</comments>
		<pubDate>Mon, 09 Jan 2012 16:55:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[RAD]]></category>
		<category><![CDATA[Rite Aid Corporation]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89426</guid>
		<description><![CDATA[Subsequent to the announcement of Walgreen’s (WAG) first quarter 2012 (ended November 30) results on December 21, 2011, majority of the analysts have reduced their estimates for the forthcoming period. Previous Quarter Highlights Walgreen reported first quarter 2012 EPS of 63 cents, a penny higher than the year-ago quarter earnings but missed the Zacks Consensus Estimate of 67 cents. The result includes a negative impact of 1 cent per share related to the delay in the cough/cold and flu season, 1 cent in comparable pharmacy sales related to the non-renewal of the Express Script (ESRX) contract and 1 cent in related expenses. Revenues rose 4.7% year over year to $18.2 billion and were in line with the Zacks Consensus Estimate. Comparable store sales (those open for more than a year) ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/09/wag-walgreens-2012-first-quarter-earnings-scorecard/89426/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ATHN) Grading the Investment U Gurus 2011: Marc Lichtenfeld</title>
		<link>http://www.stockbloghub.com/2012/01/09/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld-2/89047</link>
		<comments>http://www.stockbloghub.com/2012/01/09/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld-2/89047#comments</comments>
		<pubDate>Mon, 09 Jan 2012 16:44:49 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Business Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[AINV]]></category>
		<category><![CDATA[Allegheny Technologies Inc]]></category>
		<category><![CDATA[Apollo Investment Corporation]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[ATI]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[Capstead Mortgage Corporation]]></category>
		<category><![CDATA[CMO]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FAST]]></category>
		<category><![CDATA[Fastenal Company]]></category>
		<category><![CDATA[Genuine Parts Company]]></category>
		<category><![CDATA[GPC]]></category>
		<category><![CDATA[ISIS]]></category>
		<category><![CDATA[Isis Pharmaceuticals Inc]]></category>
		<category><![CDATA[JOE]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[MDP]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Meredith Corporation]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[NOC]]></category>
		<category><![CDATA[Northrop Grumman Corporation]]></category>
		<category><![CDATA[Old Republic International Corporation]]></category>
		<category><![CDATA[ORI]]></category>
		<category><![CDATA[The St. Joe Company]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VF Corporation]]></category>
		<category><![CDATA[VFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89047</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U Senior Analyst Tuesday, December 20, 2011: Issue #1668 I’m excited when my kids bring home their report cards. They’re terrific students, work hard and always bring home good grades. However, it’s always a little nerve-wracking to tabulate my own report card based on my market calls at the end of the year. The market isn’t nearly as forgiving as a second grade teacher. But nevertheless, it’s an important exercise to see what I got right and what I got wrong… what I may have been a little “early” on. So here goes: In my January 14 column, I talked about the rising trend of healthcare information technology and said two of my favorite stocks in the space were AthenaHealth (Nasdaq: ATHN) and McKesson (NYSE: MCK). ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/09/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld-2/89047/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Walgreen Braves Express Scripts Loss</title>
		<link>http://www.stockbloghub.com/2012/01/03/esrx-walgreen-braves-express-scripts-loss/89521</link>
		<comments>http://www.stockbloghub.com/2012/01/03/esrx-walgreen-braves-express-scripts-loss/89521#comments</comments>
		<pubDate>Tue, 03 Jan 2012 19:16:05 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[SUPERVALU Inc.]]></category>
		<category><![CDATA[SVU]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89521</guid>
		<description><![CDATA[The six-month dispute with Express Scripts (ESRX) took its toll on Walgreen’s (WAG) recently released first quarter fiscal 2012 results. The company’s bottom-line was impacted by 2 cents per share from the loss of pharmacy sales and expenses associated with the dispute. If a contract renewal is not finalized, effective January 1, 2012, Walgreen’s 7,800 pharmacies will not be a part of Express Scripts’ pharmacy provider network. The contract accounted for $5.3 billion of sales in fiscal 2011 as Express Scripts processed 88 million prescriptions filled by Walgreens. In the recently concluded quarter the pharmacy benefit manager processed as much as 26 million prescriptions from Walgreen. The wrangle would undoubtedly have an adverse impact on Walgreen’s sales, earnings and cash flow, going by the company’s recently filed 10Q. However, the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/03/esrx-walgreen-braves-express-scripts-loss/89521/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen Plans to Offset Express Scripts Loss</title>
		<link>http://www.stockbloghub.com/2012/01/03/wag-walgreen-plans-to-offset-express-scripts-loss/89549</link>
		<comments>http://www.stockbloghub.com/2012/01/03/wag-walgreen-plans-to-offset-express-scripts-loss/89549#comments</comments>
		<pubDate>Tue, 03 Jan 2012 19:05:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[SUPERVALU Inc.]]></category>
		<category><![CDATA[SVU]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89549</guid>
		<description><![CDATA[Walgreen (WAG) is commencing the New Year with efforts aimed at minimizing the impact of the non-renewal of the Express Scripts (ESRX) contract, which has just lapsed. With the intention of retaining Express Scripts’ clients, Walgreen recently came up with its comprehensive Patient Transition Plan, which will help smoothe the transition of existing members of the Express Scripts pharmacy network to another community pharmacy. Under this plan, Walgreen is providing several discounts to the members of Walgreen Prescriptions Savings Club, which facilitates savings on over 8,000 brand names and all generic drugs. The six-month dispute regarding the Express Scripts contract took its toll on Walgreen’s first quarter 2012 results. The company’s bottom-line was impacted by 2 cents per share from the loss of pharmacy sales and expenses associated with the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/03/wag-walgreen-plans-to-offset-express-scripts-loss/89549/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Corporation to Attend Healthcare Conference</title>
		<link>http://www.stockbloghub.com/2011/12/30/cvs-cvs-caremark-corporation-to-attend-healthcare-conference/89481</link>
		<comments>http://www.stockbloghub.com/2011/12/30/cvs-cvs-caremark-corporation-to-attend-healthcare-conference/89481#comments</comments>
		<pubDate>Fri, 30 Dec 2011 18:17:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89481</guid>
		<description><![CDATA[The leading provider of prescriptions and related health care services in the US, CVS Caremark Corporation (CVS) has decided to participate in the annual JP Morgan Healthcare Conference scheduled on January 10, 2012. The company will be represented by its president and CEO, Mr. Larry Merlo, at the conference. Currently, CVS Caremark is ranked among the top three pharmacy benefit managers (PBM) in the US. The other big players in this chart are Express Scripts (ESRX) and Medco Health Solutions (MHS). Together these three companies control roughly 50% of the market by covering approximately 240 million prescription drug consumers annually. Rhode Island-based CVS Caremark is a combination of a PBM as well as retail drug chain. In terms of contractual arrangements with large plan sponsors, CVS Caremark holds a leading ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/30/cvs-cvs-caremark-corporation-to-attend-healthcare-conference/89481/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ATHN) Grading the Investment U Gurus 2011: Marc Lichtenfeld</title>
		<link>http://www.stockbloghub.com/2011/12/21/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld/88979</link>
		<comments>http://www.stockbloghub.com/2011/12/21/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld/88979#comments</comments>
		<pubDate>Wed, 21 Dec 2011 17:42:14 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Business Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[AINV]]></category>
		<category><![CDATA[Allegheny Technologies Inc]]></category>
		<category><![CDATA[Apollo Investment Corporation]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[ATI]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[Capstead Mortgage Corporation]]></category>
		<category><![CDATA[CMO]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FAST]]></category>
		<category><![CDATA[Fastenal Company]]></category>
		<category><![CDATA[Genuine Parts Company]]></category>
		<category><![CDATA[GPC]]></category>
		<category><![CDATA[ISIS]]></category>
		<category><![CDATA[Isis Pharmaceuticals Inc]]></category>
		<category><![CDATA[JOE]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[MDP]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Meredith Corporation]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[NOC]]></category>
		<category><![CDATA[Northrop Grumman Corporation]]></category>
		<category><![CDATA[Old Republic International Corporation]]></category>
		<category><![CDATA[ORI]]></category>
		<category><![CDATA[The St. Joe Company]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VF Corporation]]></category>
		<category><![CDATA[VFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=88979</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U Senior Analyst Tuesday, December 20, 2011: Issue #1668 I’m excited when my kids bring home their report cards. They’re terrific students, work hard and always bring home good grades. However, it’s always a little nerve-wracking to tabulate my own report card based on my market calls at the end of the year. The market isn’t nearly as forgiving as a second grade teacher. But nevertheless, it’s an important exercise to see what I got right and what I got wrong… what I may have been a little “early” on. So here goes: In my January 14 column, I talked about the rising trend of healthcare information technology and said two of my favorite stocks in the space were AthenaHealth (Nasdaq: ATHN) and McKesson (NYSE: MCK). ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/21/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld/88979/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark  Launches New Pharmacy Advisor Program</title>
		<link>http://www.stockbloghub.com/2011/11/14/cvs-cvs-caremark-launches-new-pharmacy-advisor-program/86901</link>
		<comments>http://www.stockbloghub.com/2011/11/14/cvs-cvs-caremark-launches-new-pharmacy-advisor-program/86901#comments</comments>
		<pubDate>Mon, 14 Nov 2011 18:00:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86901</guid>
		<description><![CDATA[CVS Caremark (CVS) recently launched a new Pharmacy Advisor program to help treat chronic cardiovascular illness. The Pharmacy Advisor for chronic cardiovascular care will primarily focus on medication adherence for persistent illnesses such as high blood pressure, high cholesterol, coronary artery disease (CAD) and congestive heart failure (CHF). It has been noted that high blood pressure single-handedly affects one out of three adults, with the health care system costing roughly $76 billion annually. This program is based on the research done by the company along with Harvard University, Brigham and Women&#8217;s Hospital. The research, published in a healthcare journal in January, found that proper medication adherence can save nearly $4,000 hypertension patients, $1,200 high cholesterol patients and $8,000 CHF patients annually. We are encouraged by the improved performance of CVS ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/14/cvs-cvs-caremark-launches-new-pharmacy-advisor-program/86901/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Analyst Maintains Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2011/11/12/mhs-medco-analyst-maintains-shares-at-neutral-2/86959</link>
		<comments>http://www.stockbloghub.com/2011/11/12/mhs-medco-analyst-maintains-shares-at-neutral-2/86959#comments</comments>
		<pubDate>Sat, 12 Nov 2011 21:46:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86959</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $56.00. During the third quarter of fiscal 2011, Medco reported adjusted EPS of $1.07, beating the Zacks Consensus Estimate by 2 cents and 12.6% higher than the year-ago quarter level. Revenues increased 4.1% year over year to $17.0 billion in the quarter, in line with the Zacks Consensus Estimate. The increase in revenue was primarily driven by contributions from significant client wins coupled with higher prices charged for branded drugs, partially offset by higher volumes of lower-priced generic drugs. In fiscal 2010, Medco’s top ten clients (based on revenues) contributed approximately 47% to net revenues. Its largest client, UnitedHealth (UNH) accounted for 17% of net revenues. However, in July 2011, Medco failed to renew its ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/12/mhs-medco-analyst-maintains-shares-at-neutral-2/86959/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Posts a Strong Quarter</title>
		<link>http://www.stockbloghub.com/2011/11/06/cvs-cvs-caremark-posts-a-strong-quarter/86465</link>
		<comments>http://www.stockbloghub.com/2011/11/06/cvs-cvs-caremark-posts-a-strong-quarter/86465#comments</comments>
		<pubDate>Sun, 06 Nov 2011 20:15:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86465</guid>
		<description><![CDATA[CVS Caremark (CVS) reported third quarter 2011 EPS of 65 cents, 8.3% up year over year. However, after excluding the impact of certain one-time items, adjusted EPS came in at 70 cents, surpassing the Zacks Consensus Estimate of 67 cents and 9.3% higher than the year-ago quarter adjusted EPS. Net revenue increased 12.5% year over year to $26.7 billion, almost in line with the Zacks Consensus Estimate. The Pharmacy Services segment posted a robust 25.8% increase in revenues to $14.8 billion during the reported quarter. The significant growth was primarily on the back of the long-term contract with Aetna (AET) as well as the acquisition of the Medicare Part D business of Universal American Corp. (UAM). These contracts, combined with an increase in covered lives in the company’s existing Medicare ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/06/cvs-cvs-caremark-posts-a-strong-quarter/86465/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Express Scripts Quarterly Report Beats by a Penny</title>
		<link>http://www.stockbloghub.com/2011/10/26/esrx-express-scripts-quarterly-report-beats-by-a-penny/85930</link>
		<comments>http://www.stockbloghub.com/2011/10/26/esrx-express-scripts-quarterly-report-beats-by-a-penny/85930#comments</comments>
		<pubDate>Wed, 26 Oct 2011 16:18:31 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=85930</guid>
		<description><![CDATA[Express Scripts Inc.’s (ESRX) third quarter 2011 earnings of 79 cents per share (excluding special items) were a penny above the Zacks Consensus Estimate and 22% above the year-ago adjusted earnings of 65 cents per share. The jump in earnings is attributable to lower selling, general and administrative expenses and a lower share count compared with the year-ago quarter. Quarterly Details Third quarter revenues of $11.6 billion surpassed the Zacks Consensus Estimate of $11.4 billion and the year ago revenues of $11.3 billion. Adjusted gross profit for the quarter improved 7% to $864.3 million, and adjusted selling, general and administrative expenses decreased 6.2% to $200.3 million. Total adjusted claims at Express Scripts for the reported quarter came in at 160.5 million against 162.5 million in the third quarter of 2010. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/26/esrx-express-scripts-quarterly-report-beats-by-a-penny/85930/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Health Solutions and United Drug Terminate Joint Venture</title>
		<link>http://www.stockbloghub.com/2011/10/20/mhs-medco-health-solutions-and-united-drug-terminate-joint-venture/85401</link>
		<comments>http://www.stockbloghub.com/2011/10/20/mhs-medco-health-solutions-and-united-drug-terminate-joint-venture/85401#comments</comments>
		<pubDate>Thu, 20 Oct 2011 14:52:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[NHS]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=85401</guid>
		<description><![CDATA[Following the termination of the pan-European joint venture between Medco Health Solutions (MHS) and Germany-based Celesio AG, Dublin-based United Drug Plc recently decided to exit from its UK homecare partnership with Medco. As per the terms of the deal, Medco will own 100% interest in this project following the acquisition of United Drug&#8217;s 50% stake. The transaction is expected to be completed by November, 2011. However, the financial and other terms of the termination agreement remain disclosed. The joint venture, which came into existence in 2009, focused on the pharmacy homecare market in UK by providing a high level of service to patients with chronic and complex conditions and supporting the National Health Service (NHS) initiatives. We expect this move to be a hindrance for Medco in achieving its goal of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/20/mhs-medco-health-solutions-and-united-drug-terminate-joint-venture/85401/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(FTC) Medco Health Solutions and Express Script Asked for More Information from Federal Trade Commission</title>
		<link>http://www.stockbloghub.com/2011/09/12/ftc-medco-health-solutions-and-express-script-asked-for-more-information-from-federal-trade-commission/82626</link>
		<comments>http://www.stockbloghub.com/2011/09/12/ftc-medco-health-solutions-and-express-script-asked-for-more-information-from-federal-trade-commission/82626#comments</comments>
		<pubDate>Mon, 12 Sep 2011 17:26:16 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Exchange Traded Fund]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82626</guid>
		<description><![CDATA[Recently, Federal Trade Commission (FTC) requested both Medco Health Solutions (MHS) and Express Script (ESRX) to submit additional information regarding the pending acquisition deal. Under the current circumstances, the completion of the proposed acquisition can get postponed by approximately 30 days. Despite the uncertainty regarding the delay, Medco anticipates to close the deal by the first half of 2012. However, the deal is also subject to approval of the stockholders of both Express Scripts and Medco. Earlier, in July 2011, Medco announced that it will be acquired by Express Scripts for $29.1 billion in cash and stock. As per the terms of the agreement, each shareholder of Medco will receive $28.80 in cash and 0.81 shares of Express Scripts, representing a total value of $71.36 per Medco share. With the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/12/ftc-medco-health-solutions-and-express-script-asked-for-more-information-from-federal-trade-commission/82626/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Analyst Maintains Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2011/09/11/cvs-cvs-caremark-analyst-maintains-shares-at-neutral/82891</link>
		<comments>http://www.stockbloghub.com/2011/09/11/cvs-cvs-caremark-analyst-maintains-shares-at-neutral/82891#comments</comments>
		<pubDate>Sun, 11 Sep 2011 16:43:20 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82891</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $38.00. CVS reported an adjusted EPS of 65 cents in the second quarter of 2011, surpassing the Zacks Consensus Estimate by a penny but meeting the year-ago quarter’s adjusted EPS. After a period of sluggish performance, CVS’ Pharmacy Benefit Management (PBM) segment grew for the second consecutive quarter. During the quarter, this segment recorded a robust 23.2% year-over-year increase in revenues to reach $14.6 billion. The year-over upside was primarily driven by a 12-year contract with Aetna (AET), under which CVS provides PBM services to Aetna customers as well as the new acquisition of the Medicare Part D business of Universal American Corp (UAM). The company is also confident of achieving further growth in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/11/cvs-cvs-caremark-analyst-maintains-shares-at-neutral/82891/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ABC) AmerisourceBergen Analyst Reiterates Neutral on Shares</title>
		<link>http://www.stockbloghub.com/2011/08/26/abc-amerisourcebergen-analyst-reiterates-neutral-on-shares/82113</link>
		<comments>http://www.stockbloghub.com/2011/08/26/abc-amerisourcebergen-analyst-reiterates-neutral-on-shares/82113#comments</comments>
		<pubDate>Fri, 26 Aug 2011 22:29:09 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drugs Wholesale]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ABC]]></category>
		<category><![CDATA[AmerisourceBergen Corporation]]></category>
		<category><![CDATA[CAH]]></category>
		<category><![CDATA[Cardinal Health Inc.]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82113</guid>
		<description><![CDATA[We recently reiterated our Neutral recommendation on AmerisourceBergen Corporation (ABC) with a target price of $40.00. Over the last several years, the company has been benefiting from the growth of the pharmaceutical industry in the US. We believe AmerisourceBergen should continue to benefit from growth in the pharmaceutical industry, which is driven by several factors like aging population, increased use of generics, introduction of new treatments, increased use of drug therapies and favorable legislative developments. The aforesaid points are continually helping the company, which increased its 2011 earnings guidance range following the release of the third quarter fiscal 2011 financial results. AmerisourceBergen now expects 2011 earnings to lie in the range of $2.52 &#8211; $2.56 per share (previous guidance: $2.41 &#8211; $2.49). We expect fiscal 2011 earnings to increase almost ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/26/abc-amerisourcebergen-analyst-reiterates-neutral-on-shares/82113/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BIOS) BioScrip Analyst Maintains Neutral Rating on Shares</title>
		<link>http://www.stockbloghub.com/2011/08/16/bios-bioscrip-analyst-maintains-neutral-rating-on-shares/81415</link>
		<comments>http://www.stockbloghub.com/2011/08/16/bios-bioscrip-analyst-maintains-neutral-rating-on-shares/81415#comments</comments>
		<pubDate>Tue, 16 Aug 2011 16:57:27 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ABC]]></category>
		<category><![CDATA[AmerisourceBergen Corporation]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[Chico's FAS Inc.]]></category>
		<category><![CDATA[CHS]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=81415</guid>
		<description><![CDATA[We maintain our Neutral recommendation on BioScrip Inc. (BIOS) with a target price of $6.25. BioScrip reported a loss of 4 cents per share in the second quarter of fiscal 2011 compared with the year-ago quarter EPS of 6 cents. However, after deducting the impact of restructuring charges and legal settlement cost, adjusted EPS came in at 10 cents during the quarter, surpassing the Zacks Consensus Estimate of 6 cents. After a few disappointing quarters, impacted by pricing concessions on various specialty drugs, reimbursement pressures, the new industry-wide AWP standard and the overall impact of the weak economic environment, BioScrip is gradually witnessing improvement in its top line. During the second quarter, the company witnessed an 8.7% year-over-year upsidein revenues from its pharmacy services segment, partly offset by the existing ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/16/bios-bioscrip-analyst-maintains-neutral-rating-on-shares/81415/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Beats Earnings by a Penny &#8211; Guidance Narrowed</title>
		<link>http://www.stockbloghub.com/2011/08/05/cvs-cvs-caremark-beats-earnings-by-a-penny-guidance-narrowed/80662</link>
		<comments>http://www.stockbloghub.com/2011/08/05/cvs-cvs-caremark-beats-earnings-by-a-penny-guidance-narrowed/80662#comments</comments>
		<pubDate>Fri, 05 Aug 2011 17:43:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=80662</guid>
		<description><![CDATA[CVS Caremark (CVS) reported second quarter 2011 EPS of 60 cents, at par with the year-ago quarter earnings. However, after excluding the impact of certain one-time items, adjusted earnings per share came in at 65 cents, surpassing the Zacks Consensus Estimate by a penny but meeting the year-ago quarter’s adjusted earnings. Net revenues increased 10.9% year over year to $26.6 billion, in line with the Zacks Consensus Estimate. The Pharmacy Services segment recorded a robust 23.2% increase in revenues in the quarter to $14.6 billion. The significant growth was primarily driven by the long-term contract with Aetna (AET) as well as the new acquisition of the Medicare Part D business of Universal American Corp. (UAM). These contracts, combined with an increase in covered lives in the company’s existing Medicare Part ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/05/cvs-cvs-caremark-beats-earnings-by-a-penny-guidance-narrowed/80662/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Express Scripts Revenue Rises &#8211; Earnings Report In Line</title>
		<link>http://www.stockbloghub.com/2011/08/04/esrx-express-scripts-revenue-rises-earnings-report-in-line/79677</link>
		<comments>http://www.stockbloghub.com/2011/08/04/esrx-express-scripts-revenue-rises-earnings-report-in-line/79677#comments</comments>
		<pubDate>Thu, 04 Aug 2011 16:58:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ASR]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Grupo Aeroportuario Del Sureste SA de CV]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79677</guid>
		<description><![CDATA[Express Scripts Inc.’s (ESRX) second quarter 2011 earnings of 71 cents per share (excluding special items) were in line with the Zacks Consensus Estimate but were well above the year-ago adjusted earnings of 60 cents per share. The jump in earnings is attributable to reduced selling, general and administrative expenses and a lower share count as compared with the year-ago quarter. Quarterly Details Second quarter revenues of $11.36 billion surpassed the Zacks Consensus Estimate of $11.32 billion and the year ago revenues of $11.29 billion. Adjusted gross profit for the quarter improved 4.5% to $812.6 million, and adjusted selling, general and administrative expenses decreased 8.5% to $194.6 million. Total claims at Express Scripts for the reported quarter came in at 161.4 million against 164.5 million in the second quarter of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/04/esrx-express-scripts-revenue-rises-earnings-report-in-line/79677/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Express Scripts to Buy Medco Health Solutions</title>
		<link>http://www.stockbloghub.com/2011/08/04/mhs-express-scripts-to-buy-medco-health-solutions/79676</link>
		<comments>http://www.stockbloghub.com/2011/08/04/mhs-express-scripts-to-buy-medco-health-solutions/79676#comments</comments>
		<pubDate>Thu, 04 Aug 2011 16:57:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79676</guid>
		<description><![CDATA[Following the release of its second quarter of fiscal 2011 earnings, Medco Health Solutions (MHS) announced that it will be acquired by Express Scripts (ESRX) for $29.1 billion in cash and stock. As per the terms of the agreement, each shareholder of Medco will receive $28.80 in cash and 0.81 shares of Express Scripts, representing a total value of $71.36 per Medco share. This represents a premium of 28% over Medco&#8217;s closing share price on July 20, 2011. Following completion of the deal (expected in first half of 2012), Express Scripts Holding Company will be formed wherein 59% of the holding would lie with the shareholders of Express Scripts. In continuation of its series of contract losses over the last few months, Medco’s long-time negotiation with its biggest client UnitedHealth ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/04/mhs-express-scripts-to-buy-medco-health-solutions/79676/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BT) Company News for July 22, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/07/22/bt-company-news-for-july-22-2011-corporate-summary-2/79705</link>
		<comments>http://www.stockbloghub.com/2011/07/22/bt-company-news-for-july-22-2011-corporate-summary-2/79705#comments</comments>
		<pubDate>Fri, 22 Jul 2011 21:37:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Telecom Services - Foreign]]></category>
		<category><![CDATA[BB & T Corporation]]></category>
		<category><![CDATA[BBT]]></category>
		<category><![CDATA[BT]]></category>
		<category><![CDATA[BT Group plc]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[F5 Networks Inc.]]></category>
		<category><![CDATA[FFIV]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[RHI]]></category>
		<category><![CDATA[Robert Half International Inc.]]></category>
		<category><![CDATA[SFN]]></category>
		<category><![CDATA[Spherion Corporation]]></category>
		<category><![CDATA[WCC]]></category>
		<category><![CDATA[WESCO International Inc.]]></category>
		<category><![CDATA[WNS]]></category>
		<category><![CDATA[WNS (Holdings) Limited]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79705</guid>
		<description><![CDATA[•    BB&#38;T Corp. (NYSE:BBT) reported Q2 EPS of $0.44, slightly above the Zacks Consensus Estimate of $0.42 per share. Revenues rose 7% year-over-year to $2.18 billion, beating the Zacks Consensus Estimate of $2.148 billion •    WESCO International, Inc. (NYSE:WCC) reported Q2 EPS of $1.00, surpassing the Zacks Consensus Estimate of $0.92 per share. Revenues for the quarter rose 21.1% year-over-year to $1.52 billion •    WNS Limited (NYSE:WNS) reported Q1 EPS of $0.22, beating the Zacks Consensus Estimate of $0.15 per share. Revenues for the quarter rose 9.5% year-over-year to $97.8 million, ahead of the Zacks Consensus Estimate of $94.0 million •    Express Scripts, Inc. (NASDAQ:ESRX) reported Q2 EPS of $0.71, in line with the Zacks Consensus Estimate. However, revenues for the quarter rose 0.6% year-over-year to $11.36 billion, higher than ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/22/bt-company-news-for-july-22-2011-corporate-summary-2/79705/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BT) Company News for July 22, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/07/22/bt-company-news-for-july-22-2011-corporate-summary/79658</link>
		<comments>http://www.stockbloghub.com/2011/07/22/bt-company-news-for-july-22-2011-corporate-summary/79658#comments</comments>
		<pubDate>Fri, 22 Jul 2011 16:49:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Telecom Services - Foreign]]></category>
		<category><![CDATA[BB & T Corporation]]></category>
		<category><![CDATA[BBT]]></category>
		<category><![CDATA[BT]]></category>
		<category><![CDATA[BT Group plc]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[F5 Networks Inc.]]></category>
		<category><![CDATA[FFIV]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[RHI]]></category>
		<category><![CDATA[Robert Half International Inc.]]></category>
		<category><![CDATA[SFN]]></category>
		<category><![CDATA[Spherion Corporation]]></category>
		<category><![CDATA[WCC]]></category>
		<category><![CDATA[WESCO International Inc.]]></category>
		<category><![CDATA[WNS]]></category>
		<category><![CDATA[WNS (Holdings) Limited]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79658</guid>
		<description><![CDATA[•    BB&#38;T Corp. (NYSE:BBT) reported Q2 EPS of $0.44, slightly above the Zacks Consensus Estimate of $0.42 per share. Revenues rose 7% year-over-year to $2.18 billion, beating the Zacks Consensus Estimate of $2.148 billion •    WESCO International, Inc. (NYSE:WCC) reported Q2 EPS of $1.00, surpassing the Zacks Consensus Estimate of $0.92 per share. Revenues for the quarter rose 21.1% year-over-year to $1.52 billion •    WNS Limited (NYSE:WNS) reported Q1 EPS of $0.22, beating the Zacks Consensus Estimate of $0.15 per share. Revenues for the quarter rose 9.5% year-over-year to $97.8 million, ahead of the Zacks Consensus Estimate of $94.0 million •    Express Scripts, Inc. (NASDAQ:ESRX) reported Q2 EPS of $0.71, in line with the Zacks Consensus Estimate. However, revenues for the quarter rose 0.6% year-over-year to $11.36 billion, higher than ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/22/bt-company-news-for-july-22-2011-corporate-summary/79658/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Health Solutions 2011 Second Quarter Earnings Preview</title>
		<link>http://www.stockbloghub.com/2011/07/20/mhs-medco-health-solutions-2011-second-quarter-earnings-preview/79454</link>
		<comments>http://www.stockbloghub.com/2011/07/20/mhs-medco-health-solutions-2011-second-quarter-earnings-preview/79454#comments</comments>
		<pubDate>Wed, 20 Jul 2011 15:27:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79454</guid>
		<description><![CDATA[Medco Health Solutions Inc. (MHS) is scheduled to release its second-quarter 2011 earnings on July 21, 2011 before the market opens. The company is expected to report EPS of 94 cents on revenues of $17.08 billion during the quarter, according to Zacks Consensus Estimates. With respect to earnings surprises, Medco has exceeded the expectations in three out of the trailing four quarters. During the fourth quarter of fiscal 2010, the company reported in line results. The company has positive average earnings surprise of 2.70%. Along with the first quarter results, Medco raised its guidance for fiscal 2011 based on solid growth across all its segments. The company expects to deliver adjusted EPS in the range of $4.02-$4.12 (previous range of $3.80-$3.93) representing growth of 13%–16%. Previous Quarter Highlights Medco reported ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/20/mhs-medco-health-solutions-2011-second-quarter-earnings-preview/79454/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AAPL) 2011 Second Quarter Earnings Preview &#8211; Detailed</title>
		<link>http://www.stockbloghub.com/2011/07/18/aapl-2011-second-quarter-earnings-preview-detailed/79251</link>
		<comments>http://www.stockbloghub.com/2011/07/18/aapl-2011-second-quarter-earnings-preview-detailed/79251#comments</comments>
		<pubDate>Mon, 18 Jul 2011 21:09:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Personal Computers]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[8x8 Inc]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[ABB]]></category>
		<category><![CDATA[ABB Limited]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Acacia Research Corporation]]></category>
		<category><![CDATA[Acme Packet Inc]]></category>
		<category><![CDATA[ACTG]]></category>
		<category><![CDATA[ADS]]></category>
		<category><![CDATA[Advanced Micro Devices Inc.]]></category>
		<category><![CDATA[AF]]></category>
		<category><![CDATA[Air Products & Chemicals Inc.]]></category>
		<category><![CDATA[Alaska Air Group Inc.]]></category>
		<category><![CDATA[ALB]]></category>
		<category><![CDATA[Albemarle Corporation]]></category>
		<category><![CDATA[Alexion Pharmaceuticals Inc]]></category>
		<category><![CDATA[ALK]]></category>
		<category><![CDATA[Alliance Data Systems Corporation]]></category>
		<category><![CDATA[Altera Corporation]]></category>
		<category><![CDATA[ALTR]]></category>
		<category><![CDATA[Altria Group Inc.]]></category>
		<category><![CDATA[ALV]]></category>
		<category><![CDATA[ALXN]]></category>
		<category><![CDATA[AMD]]></category>
		<category><![CDATA[American Express Company]]></category>
		<category><![CDATA[AmeriServ Financial Inc]]></category>
		<category><![CDATA[Amphenol Corporation]]></category>
		<category><![CDATA[AMR]]></category>
		<category><![CDATA[AMR Corporation]]></category>
		<category><![CDATA[AMSG]]></category>
		<category><![CDATA[AmSurg Corporation]]></category>
		<category><![CDATA[AMTD]]></category>
		<category><![CDATA[AO Smith Corporation]]></category>
		<category><![CDATA[AOS]]></category>
		<category><![CDATA[APD]]></category>
		<category><![CDATA[APH]]></category>
		<category><![CDATA[APKT]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[AptarGroup Inc.]]></category>
		<category><![CDATA[ARB]]></category>
		<category><![CDATA[Arbitron Inc]]></category>
		<category><![CDATA[ASBC]]></category>
		<category><![CDATA[ASR]]></category>
		<category><![CDATA[ASRV]]></category>
		<category><![CDATA[Associated Banc-Corp]]></category>
		<category><![CDATA[Astoria Financial Corporation]]></category>
		<category><![CDATA[AT Cross Company]]></category>
		<category><![CDATA[AT&T Inc.]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[ATMI]]></category>
		<category><![CDATA[ATMI Inc.]]></category>
		<category><![CDATA[ATR]]></category>
		<category><![CDATA[ATX]]></category>
		<category><![CDATA[Autoliv Inc.]]></category>
		<category><![CDATA[AVID]]></category>
		<category><![CDATA[Avid Technology Inc]]></category>
		<category><![CDATA[AXP]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Badger Meter Inc]]></category>
		<category><![CDATA[BancFirst Corporation]]></category>
		<category><![CDATA[Banco Latinoamericano de Exportaciones SA]]></category>
		<category><![CDATA[Bancorp Rhode Island Inc]]></category>
		<category><![CDATA[BANF]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[Banner Corporation]]></category>
		<category><![CDATA[BANR]]></category>
		<category><![CDATA[BARI]]></category>
		<category><![CDATA[BAS]]></category>
		<category><![CDATA[Basic Energy Services Inc.]]></category>
		<category><![CDATA[BAX]]></category>
		<category><![CDATA[Baxter International Inc]]></category>
		<category><![CDATA[BB & T Corporation]]></category>
		<category><![CDATA[BBT]]></category>
		<category><![CDATA[BJ's Restaurants Inc.]]></category>
		<category><![CDATA[BJRI]]></category>
		<category><![CDATA[BK]]></category>
		<category><![CDATA[BlackRock Inc.]]></category>
		<category><![CDATA[BLDR]]></category>
		<category><![CDATA[BLK]]></category>
		<category><![CDATA[BLX]]></category>
		<category><![CDATA[BMI]]></category>
		<category><![CDATA[BOOT]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BPOP]]></category>
		<category><![CDATA[BRO]]></category>
		<category><![CDATA[Brown & Brown Inc.]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[BTU]]></category>
		<category><![CDATA[Builders FirstSource Inc]]></category>
		<category><![CDATA[BX]]></category>
		<category><![CDATA[CA]]></category>
		<category><![CDATA[Ca Technologies]]></category>
		<category><![CDATA[CAKE]]></category>
		<category><![CDATA[Cardinal Financial Corporation]]></category>
		<category><![CDATA[Cash America International Inc]]></category>
		<category><![CDATA[CAT]]></category>
		<category><![CDATA[Caterpillar Inc.]]></category>
		<category><![CDATA[Cathay General Bancorp]]></category>
		<category><![CDATA[CATY]]></category>
		<category><![CDATA[CB]]></category>
		<category><![CDATA[CBE]]></category>
		<category><![CDATA[CBI]]></category>
		<category><![CDATA[CCK]]></category>
		<category><![CDATA[CE]]></category>
		<category><![CDATA[Celanese Corporation]]></category>
		<category><![CDATA[Celestica Inc.]]></category>
		<category><![CDATA[Cemex S.A.B. de C.V.]]></category>
		<category><![CDATA[Central Valley Community Bancorp]]></category>
		<category><![CDATA[Cepheid]]></category>
		<category><![CDATA[CFNL]]></category>
		<category><![CDATA[Charles Schwab Corporation]]></category>
		<category><![CDATA[Check Point Software Technologies Limited]]></category>
		<category><![CDATA[Chicago Bridge & Iron Company N.V.]]></category>
		<category><![CDATA[Chipotle Mexican Grill Inc.]]></category>
		<category><![CDATA[CHKP]]></category>
		<category><![CDATA[Cintas Corporation]]></category>
		<category><![CDATA[Cirrus Logic Inc.]]></category>
		<category><![CDATA[City National Corporation]]></category>
		<category><![CDATA[CLB]]></category>
		<category><![CDATA[CLS]]></category>
		<category><![CDATA[CMA]]></category>
		<category><![CDATA[CMCO]]></category>
		<category><![CDATA[CMG]]></category>
		<category><![CDATA[CNS]]></category>
		<category><![CDATA[CoBiz Financial Inc]]></category>
		<category><![CDATA[COBZ]]></category>
		<category><![CDATA[Coca-Cola FEMSA S.A.B de CV]]></category>
		<category><![CDATA[Cohen & Steers Inc.]]></category>
		<category><![CDATA[COHU]]></category>
		<category><![CDATA[Cohu Inc]]></category>
		<category><![CDATA[COL]]></category>
		<category><![CDATA[Columbus Mckinnon Corporation]]></category>
		<category><![CDATA[Comerica Incorporated]]></category>
		<category><![CDATA[Complete Production Services Inc]]></category>
		<category><![CDATA[Compuware Corporation]]></category>
		<category><![CDATA[Cooper Industries Limited]]></category>
		<category><![CDATA[Core Laboratories NV]]></category>
		<category><![CDATA[Covanta Holding Corporation]]></category>
		<category><![CDATA[CPHD]]></category>
		<category><![CDATA[CPWR]]></category>
		<category><![CDATA[CPX]]></category>
		<category><![CDATA[Crown Holdings Inc.]]></category>
		<category><![CDATA[CRUS]]></category>
		<category><![CDATA[CSH]]></category>
		<category><![CDATA[CSX]]></category>
		<category><![CDATA[CSX Corporation]]></category>
		<category><![CDATA[CTAS]]></category>
		<category><![CDATA[CVA]]></category>
		<category><![CDATA[CVB Financial Corporation]]></category>
		<category><![CDATA[CVBF]]></category>
		<category><![CDATA[CVCY]]></category>
		<category><![CDATA[CX]]></category>
		<category><![CDATA[CY]]></category>
		<category><![CDATA[Cymer Inc.]]></category>
		<category><![CDATA[CYMI]]></category>
		<category><![CDATA[CYN]]></category>
		<category><![CDATA[Cypress Semiconductor Corporation]]></category>
		<category><![CDATA[CYT]]></category>
		<category><![CDATA[Cytec Industries Inc.]]></category>
		<category><![CDATA[DAL]]></category>
		<category><![CDATA[Danaher Corporation]]></category>
		<category><![CDATA[Datalink Corporation]]></category>
		<category><![CDATA[Delta Air Lines Inc.]]></category>
		<category><![CDATA[DGII]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[DHR]]></category>
		<category><![CDATA[Diamond Offshore Drilling Inc]]></category>
		<category><![CDATA[Digi International Inc.]]></category>
		<category><![CDATA[DO]]></category>
		<category><![CDATA[DOV]]></category>
		<category><![CDATA[Dover Corporation]]></category>
		<category><![CDATA[DTLK]]></category>
		<category><![CDATA[E*TRADE Financial Corporation]]></category>
		<category><![CDATA[Eagle Bancorp Inc]]></category>
		<category><![CDATA[East West Bancorp Inc]]></category>
		<category><![CDATA[Eastern Virginia Bankshares Inc]]></category>
		<category><![CDATA[EastGroup Properties Inc]]></category>
		<category><![CDATA[EBAY]]></category>
		<category><![CDATA[eBay Inc.]]></category>
		<category><![CDATA[ECA]]></category>
		<category><![CDATA[EDR]]></category>
		<category><![CDATA[EDU]]></category>
		<category><![CDATA[Education Realty Trust Inc]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EFII]]></category>
		<category><![CDATA[EGBN]]></category>
		<category><![CDATA[EGHT]]></category>
		<category><![CDATA[EGP]]></category>
		<category><![CDATA[Electronics for Imaging Inc.]]></category>
		<category><![CDATA[ELGX]]></category>
		<category><![CDATA[Eli Lilly & Company]]></category>
		<category><![CDATA[ELS]]></category>
		<category><![CDATA[EMC]]></category>
		<category><![CDATA[EMC Corporation]]></category>
		<category><![CDATA[Encana Corporation]]></category>
		<category><![CDATA[Endologix Inc]]></category>
		<category><![CDATA[Entegris Inc]]></category>
		<category><![CDATA[ENTG]]></category>
		<category><![CDATA[Equity Lifestyles Properties Inc]]></category>
		<category><![CDATA[ERIC]]></category>
		<category><![CDATA[ESI]]></category>
		<category><![CDATA[ETFC]]></category>
		<category><![CDATA[EVBS]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[EWBC]]></category>
		<category><![CDATA[EXPO]]></category>
		<category><![CDATA[Exponent Inc.]]></category>
		<category><![CDATA[EZCORP Inc.]]></category>
		<category><![CDATA[EZPW]]></category>
		<category><![CDATA[F5 Networks Inc.]]></category>
		<category><![CDATA[FCFS]]></category>
		<category><![CDATA[FCX]]></category>
		<category><![CDATA[FFIV]]></category>
		<category><![CDATA[Fidelity National Information Services Inc]]></category>
		<category><![CDATA[Fifth Third Bancorp]]></category>
		<category><![CDATA[First Cash Financial Services Inc]]></category>
		<category><![CDATA[First Niagara Financial Group Inc]]></category>
		<category><![CDATA[FIS]]></category>
		<category><![CDATA[FITB]]></category>
		<category><![CDATA[FLEX]]></category>
		<category><![CDATA[Flextronics International Limited]]></category>
		<category><![CDATA[FLIR]]></category>
		<category><![CDATA[FLIR Systems Inc]]></category>
		<category><![CDATA[FMX]]></category>
		<category><![CDATA[FNFG]]></category>
		<category><![CDATA[Fomento Economico Mexicano S.a.b De C.v.]]></category>
		<category><![CDATA[Forest Laboratories Inc.]]></category>
		<category><![CDATA[Forward Air Corporation]]></category>
		<category><![CDATA[Freeport-McMoRan Copper & Gold Inc]]></category>
		<category><![CDATA[FRX]]></category>
		<category><![CDATA[FULT]]></category>
		<category><![CDATA[Fulton Financial Corporation]]></category>
		<category><![CDATA[FWRD]]></category>
		<category><![CDATA[Gannett Company Inc]]></category>
		<category><![CDATA[Gardner Denver Inc.]]></category>
		<category><![CDATA[GCI]]></category>
		<category><![CDATA[GDI]]></category>
		<category><![CDATA[GE]]></category>
		<category><![CDATA[General Electric Company]]></category>
		<category><![CDATA[Gentex Corporation]]></category>
		<category><![CDATA[GLF]]></category>
		<category><![CDATA[Glimcher Realty Trust]]></category>
		<category><![CDATA[Global Payments Inc]]></category>
		<category><![CDATA[GNTX]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[Goodrich Corporation]]></category>
		<category><![CDATA[GPN]]></category>
		<category><![CDATA[GR]]></category>
		<category><![CDATA[GRT]]></category>
		<category><![CDATA[Grupo Aeroportuario Centro Norte S.A. de C.V.]]></category>
		<category><![CDATA[Grupo Aeroportuario Del Sureste SA de CV]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[Gulfmark Offshore Inc.]]></category>
		<category><![CDATA[GWW]]></category>
		<category><![CDATA[HAFC]]></category>
		<category><![CDATA[HAL]]></category>
		<category><![CDATA[Halliburton Company]]></category>
		<category><![CDATA[Hancock Holding Company]]></category>
		<category><![CDATA[Hanesbrands Inc.]]></category>
		<category><![CDATA[Hanmi Financial Corporation]]></category>
		<category><![CDATA[Harley-Davidson Inc.]]></category>
		<category><![CDATA[HAS]]></category>
		<category><![CDATA[Hasbro Inc.]]></category>
		<category><![CDATA[HBAN]]></category>
		<category><![CDATA[HBHC]]></category>
		<category><![CDATA[HBI]]></category>
		<category><![CDATA[Healthways Inc]]></category>
		<category><![CDATA[Heartland Express Inc]]></category>
		<category><![CDATA[HGSI]]></category>
		<category><![CDATA[HITT]]></category>
		<category><![CDATA[Hittite Microwave Corporation]]></category>
		<category><![CDATA[HNI]]></category>
		<category><![CDATA[HNI Corporation]]></category>
		<category><![CDATA[HOG]]></category>
		<category><![CDATA[HOMB]]></category>
		<category><![CDATA[Home Bancshares Inc (Conway AR)]]></category>
		<category><![CDATA[HON]]></category>
		<category><![CDATA[Honeywell International Inc.]]></category>
		<category><![CDATA[Host Hotels & Resorts Inc.]]></category>
		<category><![CDATA[HST]]></category>
		<category><![CDATA[HTLD]]></category>
		<category><![CDATA[Human Genome Sciences Inc.]]></category>
		<category><![CDATA[Huntington Bancshares Inc]]></category>
		<category><![CDATA[HWAY]]></category>
		<category><![CDATA[IBKR]]></category>
		<category><![CDATA[IBM]]></category>
		<category><![CDATA[ICLR]]></category>
		<category><![CDATA[ICON plc]]></category>
		<category><![CDATA[ICU Medical Inc]]></category>
		<category><![CDATA[ICUI]]></category>
		<category><![CDATA[IDEX Corporation]]></category>
		<category><![CDATA[IDEXX Laboratories Inc.]]></category>
		<category><![CDATA[IDXX]]></category>
		<category><![CDATA[IEX]]></category>
		<category><![CDATA[IIIN]]></category>
		<category><![CDATA[INFA]]></category>
		<category><![CDATA[Infinera Corporation]]></category>
		<category><![CDATA[INFN]]></category>
		<category><![CDATA[Informatica Corporation]]></category>
		<category><![CDATA[Ingersoll-Rand Company Limited]]></category>
		<category><![CDATA[Insteel Industries Inc.]]></category>
		<category><![CDATA[INTC]]></category>
		<category><![CDATA[Intel Corporation]]></category>
		<category><![CDATA[Interactive Brokers Group Inc]]></category>
		<category><![CDATA[International Business Machines]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[IR]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[ITT Educational Services Inc.]]></category>
		<category><![CDATA[Ixia]]></category>
		<category><![CDATA[JAKK]]></category>
		<category><![CDATA[JAKKS Pacific Inc.]]></category>
		<category><![CDATA[Janus Capital Group Inc.]]></category>
		<category><![CDATA[JCI]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[JNS]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Johnson Controls Inc.]]></category>
		<category><![CDATA[Kansas City Southern]]></category>
		<category><![CDATA[Kayne Anderson Energy Development Company]]></category>
		<category><![CDATA[KED]]></category>
		<category><![CDATA[KEY]]></category>
		<category><![CDATA[KeyCorp]]></category>
		<category><![CDATA[Kinder Morgan Energy Partners LP]]></category>
		<category><![CDATA[Kinder Morgan Management LLC]]></category>
		<category><![CDATA[KMP]]></category>
		<category><![CDATA[KMR]]></category>
		<category><![CDATA[KNL]]></category>
		<category><![CDATA[Knoll Inc.]]></category>
		<category><![CDATA[KO]]></category>
		<category><![CDATA[KOF]]></category>
		<category><![CDATA[KSU]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[Lacrosse Footwear Inc.]]></category>
		<category><![CDATA[Landstar System Inc.]]></category>
		<category><![CDATA[Lare Holdings Inc]]></category>
		<category><![CDATA[LaSalle Hotel Properties]]></category>
		<category><![CDATA[Lattice Semiconductor Corporation]]></category>
		<category><![CDATA[LCC]]></category>
		<category><![CDATA[LECO]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[LHO]]></category>
		<category><![CDATA[Life Time Fitness Inc.]]></category>
		<category><![CDATA[Lincoln Electric Holdings]]></category>
		<category><![CDATA[LLY]]></category>
		<category><![CDATA[Lm Ericsson Telephone Company]]></category>
		<category><![CDATA[LNCR]]></category>
		<category><![CDATA[LSCC]]></category>
		<category><![CDATA[LSTR]]></category>
		<category><![CDATA[LTM]]></category>
		<category><![CDATA[LUFK]]></category>
		<category><![CDATA[Lufkin Industries Inc.]]></category>
		<category><![CDATA[M&T Bank Corporation]]></category>
		<category><![CDATA[MAN]]></category>
		<category><![CDATA[MANH]]></category>
		<category><![CDATA[Manhattan Associates Inc.]]></category>
		<category><![CDATA[Manpower Inc.]]></category>
		<category><![CDATA[Marten Transport Limited]]></category>
		<category><![CDATA[Matthews International Corporation]]></category>
		<category><![CDATA[MATW]]></category>
		<category><![CDATA[Mb Financial Inc]]></category>
		<category><![CDATA[MBFI]]></category>
		<category><![CDATA[MBWM]]></category>
		<category><![CDATA[MCBI]]></category>
		<category><![CDATA[MCD]]></category>
		<category><![CDATA[McDonald's Corporation]]></category>
		<category><![CDATA[McMoRan Exploration Company]]></category>
		<category><![CDATA[MCRI]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Mellanox Technologies Limited]]></category>
		<category><![CDATA[Mercantile Bank Corporation]]></category>
		<category><![CDATA[Meridian Bioscience Inc.]]></category>
		<category><![CDATA[Merit Medical Systems Inc]]></category>
		<category><![CDATA[Metrocorp Bancshares Inc.]]></category>
		<category><![CDATA[MGIC Investment Corporation]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Microsoft Corporation]]></category>
		<category><![CDATA[MKS Instruments Inc.]]></category>
		<category><![CDATA[MKSI]]></category>
		<category><![CDATA[MLNX]]></category>
		<category><![CDATA[MMR]]></category>
		<category><![CDATA[MMSI]]></category>
		<category><![CDATA[MNRO]]></category>
		<category><![CDATA[MO]]></category>
		<category><![CDATA[MOH]]></category>
		<category><![CDATA[Molina Healthcare Inc.]]></category>
		<category><![CDATA[Monarch Casino & Resort Inc.]]></category>
		<category><![CDATA[Monro Muffler Brake Inc.]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MOS]]></category>
		<category><![CDATA[Mosaic Company]]></category>
		<category><![CDATA[MOSY]]></category>
		<category><![CDATA[MoSys Inc]]></category>
		<category><![CDATA[MRTN]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[MSFT]]></category>
		<category><![CDATA[MTB]]></category>
		<category><![CDATA[MTG]]></category>
		<category><![CDATA[MYE]]></category>
		<category><![CDATA[Myers Industries Inc.]]></category>
		<category><![CDATA[NAFC]]></category>
		<category><![CDATA[Nash FInch Company]]></category>
		<category><![CDATA[NCR]]></category>
		<category><![CDATA[NCR Corporation]]></category>
		<category><![CDATA[NE]]></category>
		<category><![CDATA[NetScout Systems Inc]]></category>
		<category><![CDATA[New Oriental Education & Technology Group]]></category>
		<category><![CDATA[New York Community Bancorp Inc]]></category>
		<category><![CDATA[Newfield Exploration Company]]></category>
		<category><![CDATA[NFX]]></category>
		<category><![CDATA[Noble Corporation]]></category>
		<category><![CDATA[NOK]]></category>
		<category><![CDATA[Nokia Corporation]]></category>
		<category><![CDATA[Northern Trust Corporation]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NTCT]]></category>
		<category><![CDATA[NTRS]]></category>
		<category><![CDATA[Nucor Corporation]]></category>
		<category><![CDATA[NUE]]></category>
		<category><![CDATA[NVE Corporation]]></category>
		<category><![CDATA[NVEC]]></category>
		<category><![CDATA[NVR]]></category>
		<category><![CDATA[NVR Inc.]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[NYB]]></category>
		<category><![CDATA[NYT]]></category>
		<category><![CDATA[OceanFirst Financial Corporation]]></category>
		<category><![CDATA[OCFC]]></category>
		<category><![CDATA[OFG]]></category>
		<category><![CDATA[Old Republic International Corporation]]></category>
		<category><![CDATA[Olin Corporation]]></category>
		<category><![CDATA[OLN]]></category>
		<category><![CDATA[OMAB]]></category>
		<category><![CDATA[OMC]]></category>
		<category><![CDATA[Omnicom Group Inc.]]></category>
		<category><![CDATA[ORI]]></category>
		<category><![CDATA[Oriental Financial Group Inc.]]></category>
		<category><![CDATA[Pacific Continental Corporation]]></category>
		<category><![CDATA[Packaging Corporation of America]]></category>
		<category><![CDATA[PAG]]></category>
		<category><![CDATA[Park National Corporation]]></category>
		<category><![CDATA[PBCT]]></category>
		<category><![CDATA[PCBK]]></category>
		<category><![CDATA[PCP]]></category>
		<category><![CDATA[PDS]]></category>
		<category><![CDATA[Peabody Energy Corporation]]></category>
		<category><![CDATA[PENN]]></category>
		<category><![CDATA[Penn National Gaming Inc.]]></category>
		<category><![CDATA[Penske Automotive Group Inc.]]></category>
		<category><![CDATA[Peoples United Financial Inc]]></category>
		<category><![CDATA[PEP]]></category>
		<category><![CDATA[Pepsico Inc.]]></category>
		<category><![CDATA[PetMed Express Inc.]]></category>
		<category><![CDATA[PETS]]></category>
		<category><![CDATA[PGI]]></category>
		<category><![CDATA[Philip Morris International Inc]]></category>
		<category><![CDATA[PII]]></category>
		<category><![CDATA[Pinnacle Financial Partners Inc]]></category>
		<category><![CDATA[Piper Jaffray Companies]]></category>
		<category><![CDATA[PJC]]></category>
		<category><![CDATA[PKG]]></category>
		<category><![CDATA[Platinum Underwriters Holdings Limited]]></category>
		<category><![CDATA[PLCM]]></category>
		<category><![CDATA[Plexus Corporation]]></category>
		<category><![CDATA[PLXS]]></category>
		<category><![CDATA[PM]]></category>
		<category><![CDATA[PMC-Sierra Inc.]]></category>
		<category><![CDATA[PMCS]]></category>
		<category><![CDATA[PNC]]></category>
		<category><![CDATA[PNC Financial Services Group Inc]]></category>
		<category><![CDATA[PNFP]]></category>
		<category><![CDATA[Polaris Industries Inc.]]></category>
		<category><![CDATA[Polycom Inc.]]></category>
		<category><![CDATA[POOL]]></category>
		<category><![CDATA[Pool Corp]]></category>
		<category><![CDATA[Popular Inc]]></category>
		<category><![CDATA[PPG]]></category>
		<category><![CDATA[PPG Industries Inc.]]></category>
		<category><![CDATA[Precision Castparts Corporation]]></category>
		<category><![CDATA[Precision Drilling Trust]]></category>
		<category><![CDATA[Premiere Global Services Inc.]]></category>
		<category><![CDATA[PRK]]></category>
		<category><![CDATA[Prosperity Bancshares Inc.]]></category>
		<category><![CDATA[PRSP]]></category>
		<category><![CDATA[PTP]]></category>
		<category><![CDATA[QCOM]]></category>
		<category><![CDATA[QUALCOMM Inc]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[RAI]]></category>
		<category><![CDATA[Raymond James Financial Inc.]]></category>
		<category><![CDATA[Renaissance Learning Inc.]]></category>
		<category><![CDATA[Renasant Corporation]]></category>
		<category><![CDATA[Reynolds American Inc.]]></category>
		<category><![CDATA[RHI]]></category>
		<category><![CDATA[Riverbed Technology Inc.]]></category>
		<category><![CDATA[RJF]]></category>
		<category><![CDATA[RLI]]></category>
		<category><![CDATA[RLI Corporation]]></category>
		<category><![CDATA[RLRN]]></category>
		<category><![CDATA[RNST]]></category>
		<category><![CDATA[Robert Half International Inc.]]></category>
		<category><![CDATA[Rockwell Collins Inc.]]></category>
		<category><![CDATA[RRR]]></category>
		<category><![CDATA[RSC Holdings Inc.]]></category>
		<category><![CDATA[RT]]></category>
		<category><![CDATA[Ruby Tuesday Inc.]]></category>
		<category><![CDATA[RVBD]]></category>
		<category><![CDATA[SABA]]></category>
		<category><![CDATA[Saba Software Inc.]]></category>
		<category><![CDATA[Safeway Inc.]]></category>
		<category><![CDATA[SanDisk Corporation]]></category>
		<category><![CDATA[Sandy Spring Bancorp Inc]]></category>
		<category><![CDATA[SASR]]></category>
		<category><![CDATA[SBIB]]></category>
		<category><![CDATA[Schiff Nutrition International Inc]]></category>
		<category><![CDATA[SCHL]]></category>
		<category><![CDATA[Schlumberger Limited]]></category>
		<category><![CDATA[Scholastic Corporation]]></category>
		<category><![CDATA[SCHW]]></category>
		<category><![CDATA[SCSS]]></category>
		<category><![CDATA[Seagate Technology]]></category>
		<category><![CDATA[SEI Investments Company]]></category>
		<category><![CDATA[SEIC]]></category>
		<category><![CDATA[Select Comfort Corporation]]></category>
		<category><![CDATA[Sensient Technologies Corporation]]></category>
		<category><![CDATA[SFG]]></category>
		<category><![CDATA[SFNC]]></category>
		<category><![CDATA[Sherwin-Williams Company]]></category>
		<category><![CDATA[SHW]]></category>
		<category><![CDATA[Simmons First National Corporation]]></category>
		<category><![CDATA[Skyworks Solutions Inc.]]></category>
		<category><![CDATA[SLB]]></category>
		<category><![CDATA[SLM]]></category>
		<category><![CDATA[Slm Corporation]]></category>
		<category><![CDATA[SNA]]></category>
		<category><![CDATA[Snap-on Inc.]]></category>
		<category><![CDATA[SNDK]]></category>
		<category><![CDATA[SON]]></category>
		<category><![CDATA[Sonoco Products Company]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[StanCorp Financial Group Inc.]]></category>
		<category><![CDATA[Stanley Black & Decker]]></category>
		<category><![CDATA[Stanley Furniture Company Inc]]></category>
		<category><![CDATA[State Street Corporation]]></category>
		<category><![CDATA[Steel Dynamics Inc.]]></category>
		<category><![CDATA[Sterling Bancshares Inc]]></category>
		<category><![CDATA[STI]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[STLD]]></category>
		<category><![CDATA[STLY]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[STT]]></category>
		<category><![CDATA[STX]]></category>
		<category><![CDATA[SunTrust Banks Inc.]]></category>
		<category><![CDATA[SWK]]></category>
		<category><![CDATA[SWKS]]></category>
		<category><![CDATA[SWY]]></category>
		<category><![CDATA[SXT]]></category>
		<category><![CDATA[SY Bancorp Inc.]]></category>
		<category><![CDATA[SYBT]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[T]]></category>
		<category><![CDATA[Taubman Centers Inc.]]></category>
		<category><![CDATA[TAYC]]></category>
		<category><![CDATA[Taylor Capital Group Inc]]></category>
		<category><![CDATA[TBBK]]></category>
		<category><![CDATA[TCB]]></category>
		<category><![CDATA[TCBI]]></category>
		<category><![CDATA[TCF Financial Corporation]]></category>
		<category><![CDATA[TCO]]></category>
		<category><![CDATA[TD AMERITRADE Holding Corporation]]></category>
		<category><![CDATA[TEL]]></category>
		<category><![CDATA[Temple-Inland Inc.]]></category>
		<category><![CDATA[Terex Corporation]]></category>
		<category><![CDATA[TESS]]></category>
		<category><![CDATA[TESSCO Technologies Inc.]]></category>
		<category><![CDATA[TEX]]></category>
		<category><![CDATA[Texas Capital BancShares Inc.]]></category>
		<category><![CDATA[Textron Inc.]]></category>
		<category><![CDATA[The Bancorp Inc]]></category>
		<category><![CDATA[The Bank of New York Mellon Corporation]]></category>
		<category><![CDATA[The Blackstone Group]]></category>
		<category><![CDATA[The Cheesecake Factory Incorporated]]></category>
		<category><![CDATA[The Chubb Corporation]]></category>
		<category><![CDATA[The Coca-Cola Company]]></category>
		<category><![CDATA[The New York Times Company]]></category>
		<category><![CDATA[The Travelers Companies Inc.]]></category>
		<category><![CDATA[Thomas & Betts Corporation]]></category>
		<category><![CDATA[TIN]]></category>
		<category><![CDATA[TNB]]></category>
		<category><![CDATA[Tractor Supply Company]]></category>
		<category><![CDATA[TRIB]]></category>
		<category><![CDATA[Trinity Biotech plc]]></category>
		<category><![CDATA[TRV]]></category>
		<category><![CDATA[TSCO]]></category>
		<category><![CDATA[TXT]]></category>
		<category><![CDATA[Tyco Electronics Limited]]></category>
		<category><![CDATA[UAL]]></category>
		<category><![CDATA[UBNK]]></category>
		<category><![CDATA[Ultratech Inc.]]></category>
		<category><![CDATA[UMPQ]]></category>
		<category><![CDATA[Umpqua Holdings Corporation]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Union Pacific Corporation]]></category>
		<category><![CDATA[United Continental Holdings]]></category>
		<category><![CDATA[United Financial Bancorp]]></category>
		<category><![CDATA[United Rentals Inc]]></category>
		<category><![CDATA[United Technologies Corporation]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>
		<category><![CDATA[UNP]]></category>
		<category><![CDATA[URI]]></category>
		<category><![CDATA[US Airways Group Inc.]]></category>
		<category><![CDATA[Us Bancorp]]></category>
		<category><![CDATA[USB]]></category>
		<category><![CDATA[UTEK]]></category>
		<category><![CDATA[UTX]]></category>
		<category><![CDATA[VCBI]]></category>
		<category><![CDATA[Verizon Communications Inc.]]></category>
		<category><![CDATA[VF Corporation]]></category>
		<category><![CDATA[VFC]]></category>
		<category><![CDATA[Virginia Commerce Bancorp Inc]]></category>
		<category><![CDATA[Vitran Corp Inc]]></category>
		<category><![CDATA[VIVO]]></category>
		<category><![CDATA[VMW]]></category>
		<category><![CDATA[VMware Inc.]]></category>
		<category><![CDATA[VTNC]]></category>
		<category><![CDATA[VZ]]></category>
		<category><![CDATA[W.W. Grainger Inc]]></category>
		<category><![CDATA[WABC]]></category>
		<category><![CDATA[WAL]]></category>
		<category><![CDATA[Waste Connections Inc.]]></category>
		<category><![CDATA[Watsco Inc.]]></category>
		<category><![CDATA[WCC]]></category>
		<category><![CDATA[WCN]]></category>
		<category><![CDATA[WDC]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[WERN]]></category>
		<category><![CDATA[Werner Enterprises Inc.]]></category>
		<category><![CDATA[WESCO International Inc.]]></category>
		<category><![CDATA[Westamerica BanCorporation]]></category>
		<category><![CDATA[Westell Technologies Inc]]></category>
		<category><![CDATA[Western Alliance Bancorporation]]></category>
		<category><![CDATA[Western Digital Corporation]]></category>
		<category><![CDATA[Westwood Holdings Group Inc]]></category>
		<category><![CDATA[WFC]]></category>
		<category><![CDATA[WHG]]></category>
		<category><![CDATA[Whirlpool Corporation]]></category>
		<category><![CDATA[WHR]]></category>
		<category><![CDATA[Wipro Limited]]></category>
		<category><![CDATA[WIT]]></category>
		<category><![CDATA[WNI]]></category>
		<category><![CDATA[WNS]]></category>
		<category><![CDATA[WNS (Holdings) Limited]]></category>
		<category><![CDATA[WSO]]></category>
		<category><![CDATA[WSTL]]></category>
		<category><![CDATA[WYNN]]></category>
		<category><![CDATA[Wynn Resorts Limited]]></category>
		<category><![CDATA[Xerox Corporation]]></category>
		<category><![CDATA[Xilinx Inc.]]></category>
		<category><![CDATA[XLNX]]></category>
		<category><![CDATA[XRX]]></category>
		<category><![CDATA[XXIA]]></category>
		<category><![CDATA[Yahoo! Inc.]]></category>
		<category><![CDATA[YHOO]]></category>
		<category><![CDATA[ZION]]></category>
		<category><![CDATA[Zions BanCorporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79251</guid>
		<description><![CDATA[Earnings Preview 7/15/11 Second quarter earnings season is now under way, but things really start to move into high gear next week. There will be 348 firms reporting, and 108 of those are in the S&#38;P 500. By next Friday we should have a very good handle on how the overall earnings season will go. The firms reporting this week are sort of like a who&#8217;s who of U.S. industry including: Apple (AAPL), American Express (AXP), Bank of America (BAC), Caterpillar (CAT), General Electric (GE), International Business Machines (IBM), Intel (INTC), McDonald&#8217;s (MCD), Schlumberger (SLB) and Verizon (VZ). That is an interesting cross section of U.S. business. We have a relatively light economic data calendar, so earnings should be front and center, along with the sovereign debt situations on both ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/18/aapl-2011-second-quarter-earnings-preview-detailed/79251/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Corporation Study to Lower Treatment Costs</title>
		<link>http://www.stockbloghub.com/2011/07/08/cvs-cvs-caremark-corporation-study-to-lower-treatment-costs/78671</link>
		<comments>http://www.stockbloghub.com/2011/07/08/cvs-cvs-caremark-corporation-study-to-lower-treatment-costs/78671#comments</comments>
		<pubDate>Fri, 08 Jul 2011 20:46:57 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78671</guid>
		<description><![CDATA[The leading provider of prescriptions and related health care services in the US, CVS Caremark Corporation (CVS) along with researchers from Harvard and Brigham universities and Women&#8217;s Hospital recently stated that the extensive use of generic medicines for the treatment of chronic diseases is a cost-effective preventative health care option. A recent study in this regard shows that the use of low-cost generic drugs compared to branded medications will curtail treatment expenses considerably. A study conducted in 2008 found that the cost of treating a cardiovascular disease using branded medications was $83,327 per quality adjusted life year (QALY). However, the study conducted by the research team demonstrated that the same treatment using generics is merely $17,084 per QALY, or just 20% of the previous estimate. In an era when health ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/08/cvs-cvs-caremark-corporation-study-to-lower-treatment-costs/78671/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Health Solutions to Better Tackle Hepatitis C</title>
		<link>http://www.stockbloghub.com/2011/07/06/mhs-medco-health-solutions-to-better-tackle-hepatitis-c/78506</link>
		<comments>http://www.stockbloghub.com/2011/07/06/mhs-medco-health-solutions-to-better-tackle-hepatitis-c/78506#comments</comments>
		<pubDate>Wed, 06 Jul 2011 21:19:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Merck & Company Inc]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[MRK]]></category>
		<category><![CDATA[Vertex Pharmaceuticals Incorporated]]></category>
		<category><![CDATA[VRTX]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78506</guid>
		<description><![CDATA[Medco Health Solutions (MHS) is making attempts to curtail costs of treating patients suffering from hepatitis C (HCV). The company’s specialty pharmacy segment, Accredo Health Group, considers patient adherence to the treatment most significant as any contrary behavior could lead to liver cirrhosis and certain cancers. Accredo is optimistic about two new HCV medications &#8212; boceprevir and teleprevir &#8212; although the treatment process is quite complex and requires greater degree of adherence. In May 2011, Merck (MRK) received approval from the US Food and Drug Administration (FDA) for Victrelis (boceprevir) to treat chronic hepatitis C (CHC). The drug is approved for the treatment of CHC genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients who were left untreated or failed previous interferon and ribavirin therapy. The ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/06/mhs-medco-health-solutions-to-better-tackle-hepatitis-c/78506/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Health Solutions Aids Sanofi-Aventis Study</title>
		<link>http://www.stockbloghub.com/2011/06/28/mhs-medco-health-solutions-aids-sanofi-aventis-study/77737</link>
		<comments>http://www.stockbloghub.com/2011/06/28/mhs-medco-health-solutions-aids-sanofi-aventis-study/77737#comments</comments>
		<pubDate>Tue, 28 Jun 2011 23:31:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[E-TRACS UBS Bloomberg CMCI Livestock ETN]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Sanofi-Aventis]]></category>
		<category><![CDATA[SNY]]></category>
		<category><![CDATA[UBC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77737</guid>
		<description><![CDATA[Medco Health Solutions (MHS) and its subsidiary United BioSource Corporation (UBC) have entered into a multi-year agreement with leading pharmaceutical company Sanofi-Aventis (SNY). Under the agreement, Medco would provide real-world evidence assessments during the product’s development by Sanofi-Aventis. Financial terms of the deal were not disclosed. Following this agreement, Sanofi-Aventis would be better placed to identify patients with huge unmet medical needs. Furthermore, the companies will strive to trace out patients on whom the drugs are most effective and also generate real-world comparative effectiveness data. This is significant as some products that hold promise in early research does not deliver expected results when applied. Medco Health has been recording increase in revenues from services primarily driven by the UBC acquisition. The acquisition provides encouraging results for the company with more ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/28/mhs-medco-health-solutions-aids-sanofi-aventis-study/77737/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark to Manage CalPERS PPO</title>
		<link>http://www.stockbloghub.com/2011/06/22/cvs-cvs-caremark-to-manage-calpers-ppo/77019</link>
		<comments>http://www.stockbloghub.com/2011/06/22/cvs-cvs-caremark-to-manage-calpers-ppo/77019#comments</comments>
		<pubDate>Wed, 22 Jun 2011 14:58:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[Polypore International Inc]]></category>
		<category><![CDATA[PPO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77019</guid>
		<description><![CDATA[Recently, the California Public Employees’ Retirement System (CalPERS) selected CVS Caremark (CVS) to manage pharmacy benefits for its preferred provider organization (PPO) health plans, catering to more than 346,000 members. The three-year contract, to be effective from January 1, 2012, represents about $565 million in annual drug spending. The contract also has the option of two one-year extensions. Prior to CVS, Medco Health Solutions (MHS) has been managing the business from July 1, 2006, which is dated to expire on December 31, 2011. CalPERS is presently working with both Medco and CVS to ensure a smooth transition for its members and physicians. This contract is significant for CVS as its pharmacy benefit management (PBM) business has been witnessing several challenges over the past few quarters. CalPERS, which spends approximately $7 ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/22/cvs-cvs-caremark-to-manage-calpers-ppo/77019/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Analyst Maintains Neutral on Shares</title>
		<link>http://www.stockbloghub.com/2011/06/04/cvs-cvs-caremark-analyst-maintains-neutral-on-shares/75294</link>
		<comments>http://www.stockbloghub.com/2011/06/04/cvs-cvs-caremark-analyst-maintains-neutral-on-shares/75294#comments</comments>
		<pubDate>Sun, 05 Jun 2011 04:20:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=75294</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $41.00. CVS Caremark reported an adjusted EPS of 57 cents in the first quarter of 2011, beating the Zacks Consensus Estimate of 55 cents but trailing the year-ago quarter’s adjusted EPS of 60 cents. After sluggish performance in past several quarters, the Pharmacy Benefit Management (PBM) business of CVS registered a robust 18.4% year over year increase during the quarter to reach $14 billion. The significant upside in revenue was primarily attributed to the 12-year contract with Aetna (AET), under which CVS provides PBM services to Aetna customers. We are encouraged by the company’s initiative for further focus on its key-growth areas under the PBM segment including the acquisition of Universal American&#8216;s (UAM) Medicare ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/04/cvs-cvs-caremark-analyst-maintains-neutral-on-shares/75294/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AFL) Company News for May 31, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/05/31/afl-company-news-for-may-31-2011-corporate-summary/75182</link>
		<comments>http://www.stockbloghub.com/2011/05/31/afl-company-news-for-may-31-2011-corporate-summary/75182#comments</comments>
		<pubDate>Tue, 31 May 2011 16:59:14 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Accident & Health Insurance]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[AFL]]></category>
		<category><![CDATA[AFLAC Inc.]]></category>
		<category><![CDATA[BRCM]]></category>
		<category><![CDATA[Broadcom Corporation]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[DB]]></category>
		<category><![CDATA[Deutsche Bank AG]]></category>
		<category><![CDATA[EBAY]]></category>
		<category><![CDATA[eBay Inc.]]></category>
		<category><![CDATA[Entergy Corporation]]></category>
		<category><![CDATA[ETR]]></category>
		<category><![CDATA[FBCM]]></category>
		<category><![CDATA[FBR Capital Markets Corporation]]></category>
		<category><![CDATA[GHM]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[Graham Corporation]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[Marvell Technology Group Limited]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MRVL]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[Nasdaq OMX Group Inc]]></category>
		<category><![CDATA[NDAQ]]></category>
		<category><![CDATA[Nyse Euronext Inc]]></category>
		<category><![CDATA[NYX]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[Weyerhaeuser Company]]></category>
		<category><![CDATA[WFC]]></category>
		<category><![CDATA[WY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=75182</guid>
		<description><![CDATA[•    Marvell Technology Group Ltd. (NASDAQ:MRVL) reported first quarter fiscal 2012 adjusted earnings per share of 24 cents, 2 cents shy of the Zacks Consensus Estimate of 26 cents. Despite the miss, shares increased 8.86% in after-market trade on encouraging second quarter guidance •    Graham Corp. (AMEX:GHM) reported fourth quarter EPS of 27 cents, ahead of the Zacks Consensus Estimate of 19 cents per share •    Google Inc. (NASDAQ:GOOG) was sued by eBay Inc.&#8217;s (NASDAQ:EBAY) PayPal over allegations of stealing mobile payment technology trade secrets •    Morgan Stanley (NYSE:MS) downgraded AFLAC Inc. (NYSE:AFL) to equal weight •    It was reported that MedcoHealth Solutions Inc. (NYSE:MHS) will lose the Federal Employee Program contract to CVS Caremark Corporation (NYSE:CVS), effective January 2012 •    The Goldman Sachs Group, Inc. (NYSE:GS) upgraded its rating ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/31/afl-company-news-for-may-31-2011-corporate-summary/75182/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Analyst Maintains Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2011/05/27/mhs-medco-analyst-maintains-shares-at-neutral/74087</link>
		<comments>http://www.stockbloghub.com/2011/05/27/mhs-medco-analyst-maintains-shares-at-neutral/74087#comments</comments>
		<pubDate>Sat, 28 May 2011 04:20:55 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[E-TRACS UBS Bloomberg CMCI Livestock ETN]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[UBC]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=74087</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $67.00. Medco reported an adjusted EPS of 91 cents in the first quarter of fiscal 2011, beating both the Zacks Consensus Estimate of 88 cents and the year-ago EPS of 76 cents. Revenues increased 4.3% year over year to $17.0 billion in the quarter primarily driven by contributions from significant client wins as well as higher prices charged on branded drugs, partially offset by higher volumes of lower-priced generic drugs. However, revenues marginally missed the Zacks Consensus Estimate of $17.1 billion. The United BioSource (UBC) acquisition in September 2010 combined with the expansion of client base at Medicare Part D services resulted in a stupendous 57.5% increase in Medco’s service revenues. In the reported quarter, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/27/mhs-medco-analyst-maintains-shares-at-neutral/74087/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BIOS) BioScrip Pharmacy Accredited</title>
		<link>http://www.stockbloghub.com/2011/04/12/bios-bioscrip-pharmacy-accredited/71235</link>
		<comments>http://www.stockbloghub.com/2011/04/12/bios-bioscrip-pharmacy-accredited/71235#comments</comments>
		<pubDate>Tue, 12 Apr 2011 20:59:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71235</guid>
		<description><![CDATA[BioScrip Inc. (BIOS), a health care-related company recently received accreditation for its specialty pharmacy and mail service pharmacy from Utilization Review Accreditation Commission (URAC), a Washington-based health care accrediting organization that establishes quality standards for the health care industry. URAC reached its decision after conducting a detailed review considering 146 parameters on BioScrip’s customer service and clinical pharmacy processes. Ensuring BioScrip’s positive approach towards healthcare needs, this award is expected to improve the company’s position in the specialty pharmacy industry. BioScrip’s specialty pharmacy and mail service pharmacy provide condition-specific clinical management, distribution and reimbursement programs of oral, injectable, and IV drug products for individuals suffering from chronic conditions. BioScrip, in partnership with healthcare payers, pharmaceutical manufacturers, government agencies and physicians strive to deliver cost effective programs to patients. Presently with ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/12/bios-bioscrip-pharmacy-accredited/71235/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SIGA) These Healthcare Stocks Are Ready to Move Next Week</title>
		<link>http://www.stockbloghub.com/2011/01/07/siga-these-healthcare-stocks-are-ready-to-move-next-week/64553</link>
		<comments>http://www.stockbloghub.com/2011/01/07/siga-these-healthcare-stocks-are-ready-to-move-next-week/64553#comments</comments>
		<pubDate>Fri, 07 Jan 2011 18:11:43 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Drug Manufacturers - Other]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[CGEN]]></category>
		<category><![CDATA[Compugen Limited]]></category>
		<category><![CDATA[DCTH]]></category>
		<category><![CDATA[Delcath Systems Inc.]]></category>
		<category><![CDATA[Eli Lilly & Company]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[LLY]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Merck & Company Inc]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[MOH]]></category>
		<category><![CDATA[Molina Healthcare Inc.]]></category>
		<category><![CDATA[MRK]]></category>
		<category><![CDATA[Nektar Therapeutics]]></category>
		<category><![CDATA[NKTR]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>
		<category><![CDATA[SIGA]]></category>
		<category><![CDATA[SIGA Technologies Inc]]></category>
		<category><![CDATA[TEVA]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries Limited]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=64553</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U’s Senior Analyst Wednesday, January 5, 2011: Issue #1421 Once again, I’ve secured my golden ticket to the most important healthcare event of the year. In the past, I’ve described the JP Morgan Healthcare Conference as the Super Bowl of the healthcare investing world. That’s no exaggeration either, as industry executives and investors jet in from all over the world to attend. And with hotels, restaurants and even the 37 Starbucks in Union Square packed with people looking for and providing information, even those without an invitation still hit San Francisco just to be near the action. It’s the place to get the latest news on drug development, research funding, and the companies that could be on the cusp of greatness. And for the past few ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/01/07/siga-these-healthcare-stocks-are-ready-to-move-next-week/64553/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLXP) Salix Pharmaceuticals Posts Narrower Third Quarter 2010 Loss</title>
		<link>http://www.stockbloghub.com/2010/11/17/slxp-salix-pharmaceuticals-posts-narrower-third-quarter-2010-loss/59433</link>
		<comments>http://www.stockbloghub.com/2010/11/17/slxp-salix-pharmaceuticals-posts-narrower-third-quarter-2010-loss/59433#comments</comments>
		<pubDate>Thu, 18 Nov 2010 05:19:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Related Products]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Salix Pharmaceuticals Limited]]></category>
		<category><![CDATA[SLXP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=59433</guid>
		<description><![CDATA[Salix Pharmaceuticals, Ltd. (SLXP) posted a loss of 5 cents per share in the third quarter of 2010, narrower than the Zacks Consensus Estimate of a loss of 15 cents and the guidance provided by the company (loss of 13 cents). Salix had reported a loss of 15 cents in the year-ago quarter. Higher revenues helped the company post a narrower loss in the reported quarter. Third quarter revenues increased 22.8% to $80.6 million, mainly due to strong Xifaxan sales. Revenues were well above the company’s guidance of $73 million and the Zacks Consensus Estimate of $76 million. Quarter in Detail Salix’ third quarter performance was driven by its key product Xifaxan, which posted sales of $65.2 million, up 53%. Prescriptions grew 65% during the third quarter. Salix reported that ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/17/slxp-salix-pharmaceuticals-posts-narrower-third-quarter-2010-loss/59433/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ABC) Company News for November 2, 2010 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2010/11/02/abc-company-news-for-november-2-2010-corporate-summary/57520</link>
		<comments>http://www.stockbloghub.com/2010/11/02/abc-company-news-for-november-2-2010-corporate-summary/57520#comments</comments>
		<pubDate>Wed, 03 Nov 2010 06:26:59 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drugs Wholesale]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ABC]]></category>
		<category><![CDATA[ADM]]></category>
		<category><![CDATA[AmerisourceBergen Corporation]]></category>
		<category><![CDATA[Archer-Daniels-Midland Company]]></category>
		<category><![CDATA[BP]]></category>
		<category><![CDATA[BP plc]]></category>
		<category><![CDATA[Emerson Electric Company]]></category>
		<category><![CDATA[EMR]]></category>
		<category><![CDATA[Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[NEM]]></category>
		<category><![CDATA[Newmont Mining Corporation]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>
		<category><![CDATA[Tenet Healthcare Corporation]]></category>
		<category><![CDATA[THC]]></category>
		<category><![CDATA[United Parcel Service]]></category>
		<category><![CDATA[UPS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=57520</guid>
		<description><![CDATA[• Pfizer&#8217;s (NYSE:PFE) reported third quarter earnings of $0.54, $0.03 above Zacks estimates as revenues surged 39.2% to $16.2 billion, slightly below Zacks estimates of $16.62 billion • Archer Daniels Midland (NYSE:ADM) posted fiscal first quarter earnings of $0.54, off Zacks estimates of $0.75, on inline revenues of $16.8 billion, up 13% YoY, and beating estimates of $15.52 billion • BP (NYSE:BP) posted better-than-expected results and noted plans to consider reinstating its dividend in 2011. Likely costs for the Macondo oil spill were raised to $40 billion • AmerisourceBergen (NYSE:ABC) topped Zacks estimates by $0.02 with fourth quarter interims of $0.50, on a 5.3% revenue gain to $19.7 billion, above Zacks estimates of $19.4 billion • Medco Health (NYSE:MHS) reported estimate-topping third quarter earnings of $0.91, up from estimates of $0.88, on revenues of $16.32 ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/02/abc-company-news-for-november-2-2010-corporate-summary/57520/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PBM) Catalyst Health Solutions Acquires FutureScripts</title>
		<link>http://www.stockbloghub.com/2010/09/14/pbm-catalyst-health-solutions-acquires-futurescripts/51475</link>
		<comments>http://www.stockbloghub.com/2010/09/14/pbm-catalyst-health-solutions-acquires-futurescripts/51475#comments</comments>
		<pubDate>Tue, 14 Sep 2010 20:22:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Basic Materials]]></category>
		<category><![CDATA[Copper]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[JEF]]></category>
		<category><![CDATA[Jefferies Group Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=51475</guid>
		<description><![CDATA[Expanding its pharmacy benefit management (PBM) solutions, on Monday, Catalyst Health Solutions Inc. (CHSI) announced the purchase of all the PBM units of Independence Blue Cross (IBC) ? FutureScripts LLC and FutureScripts Secure LLC ? for an all cash transaction of $225 million. Both the entities have also received the regulatory approvals relevant for the deal. According to the terms laid, IBC has agreed to allow Catalyst Health to manage the former’s PBM service operations for a new 10-year term period. Moreover, IBC has included the future tax benefit for Catalyst Health in the deal value, based on the arrangement of the transaction. On August 4, both Catalyst Health and IBC had agreed on the terms of the deal. While Jefferies &#38; Company Inc. of Jefferies Group Inc. (JEF) acted ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/09/14/pbm-catalyst-health-solutions-acquires-futurescripts/51475/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Health Solutions Marginally Beats Earnings Expectations</title>
		<link>http://www.stockbloghub.com/2010/02/28/mhs-medco-health-solutions-marginally-beats-earnings-expectations/29175</link>
		<comments>http://www.stockbloghub.com/2010/02/28/mhs-medco-health-solutions-marginally-beats-earnings-expectations/29175#comments</comments>
		<pubDate>Mon, 01 Mar 2010 03:55:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29175</guid>
		<description><![CDATA[Medco Health Solutions (MHS) reported fourth quarter earnings of 76 cents per share, surpassing both the Zacks Consensus Estimate of 75 cents and the year-ago period results of 59 cents. For full year 2009, the company’s earnings came in at $2.83, up 21.5% compared to $2.33 in 2008. Medco, the largest pharmacy benefit manager (PBM) recorded an increase of 17.6% in revenues which came in at $15.2 billion primarily driven by contributions from significant new client wins as well as price inflation on brand-name drugs, partially offset by higher volumes of lower-priced generic drugs. For 2009, net revenues increased 16.7% to a record $59.8 billion. Revenues from Medco’s specialty pharmacy segment, Accredo Health Group Incorporatedreased 17.7% to $2.5 billion primarily due to a significant addition of new clients and organic ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/28/mhs-medco-health-solutions-marginally-beats-earnings-expectations/29175/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Express Scripts Tops Expectations and Guides Up</title>
		<link>http://www.stockbloghub.com/2010/02/25/esrx-express-scripts-tops-expectations-and-guides-up/29029</link>
		<comments>http://www.stockbloghub.com/2010/02/25/esrx-express-scripts-tops-expectations-and-guides-up/29029#comments</comments>
		<pubDate>Thu, 25 Feb 2010 20:16:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29029</guid>
		<description><![CDATA[Express Scripts Inc. (ESRX) announced better-than-expected results with fourth-quarter earnings of 97 cents per share, 7 cents above the Zacks Consensus Estimate. Earnings increased 14.1% from the year-ago period. Full year earnings were $3.58 per share, 12 cents above the Zacks Consensus Estimate and well above the year ago earnings of $3.18. Fourth quarter revenues increased a whopping 49% to $8.2 billion. Full year revenues increased 12.6% to $24.7 billion. We believe that the company benefited from new business gained through its acquisition of NextRx, the pharmacy business management (PBM) segment of WellPoint Inc. (WLP). NextRx provides PBM services to approximately 25 million Americans and manages more than 265 million adjusted prescriptions annually. We view Express Scripts’ acquisition of NextRx as a smart strategic move. The aligned business model should ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/25/esrx-express-scripts-tops-expectations-and-guides-up/29029/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Health Solutions Beats &#8211; Provides Strong Outlook</title>
		<link>http://www.stockbloghub.com/2009/11/29/mhs-medco-health-solutions-beats-provides-strong-outlook/21427</link>
		<comments>http://www.stockbloghub.com/2009/11/29/mhs-medco-health-solutions-beats-provides-strong-outlook/21427#comments</comments>
		<pubDate>Mon, 30 Nov 2009 04:56:57 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=21427</guid>
		<description><![CDATA[Medco Health Solutions (MHS) reported third quarter earnings of 75 cents per share, well above the Zacks Consensus Estimate of 71 cents as well as 63 cents reported in the year-ago period. Medco, the largest pharmacy benefit manager (PBM) recorded an increase of 17.8% in revenues which came in at $14.8 billion primarily driven by contributions from significant new client wins, as well as price inflation on brand-name drugs, partially offset by higher volumes of lower-priced generic drugs. Revenues from MHS’ specialty pharmacy segment, Accredo Health Group increased 19.2% to $2.4 billion primarily due to significant addition of new clients and organic growth. The reported quarter has been quite significant for Medco. The huge acceptance of generic drugs (they have higher margins for PBMs compared to branded drugs) is evident ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/29/mhs-medco-health-solutions-beats-provides-strong-outlook/21427/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BIOS) BioScrip Earnings Report Beats Forecasts in Q3</title>
		<link>http://www.stockbloghub.com/2009/11/02/bios-bioscrip-earnings-report-beats-forecasts-in-q3/19422</link>
		<comments>http://www.stockbloghub.com/2009/11/02/bios-bioscrip-earnings-report-beats-forecasts-in-q3/19422#comments</comments>
		<pubDate>Mon, 02 Nov 2009 21:28:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=19422</guid>
		<description><![CDATA[BioScrip, Inc. (BIOS) reported third-quarter earnings of 14 cents per share, beating the Zacks Consensus Estimate of 10 cents. The company reported earnings of 6 cents in the year-ago period. Although earnings were better than expected, revenues declined 7.2% to $333.5 million. While the specialty business contributed $279 million to revenues, the pharmacy benefit management [PBM] business posted revenues of $54.5 million. The decline in revenues was mainly due to the elimination of the Medicare Competitive Acquisition Program and the termination of the United Health Group organ transplant and HIV/AIDS contracts. This was partially offset by increased sales of higher margin infusion therapies and other specialty sales. The company reported a sequential growth of 3% in specialty sales with several therapeutic areas like iron overload, multiple sclerosis [MS], oncology and ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/02/bios-bioscrip-earnings-report-beats-forecasts-in-q3/19422/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Express Scripts&#8217; Earnings Report is In-Line With Forecasts</title>
		<link>http://www.stockbloghub.com/2009/11/01/esrx-express-scripts-earnings-report-is-in-line-with-forecasts/19229</link>
		<comments>http://www.stockbloghub.com/2009/11/01/esrx-express-scripts-earnings-report-is-in-line-with-forecasts/19229#comments</comments>
		<pubDate>Sun, 01 Nov 2009 21:41:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=19229</guid>
		<description><![CDATA[Express Scripts Inc. (ESRX) announced third-quarter earnings of 81 cents per share, in-line with the Zacks Consensus Estimate as well as last year&#8217;s profit. Revenues, however Incorporatedreased 3% to $5.6 billion with product revenues increasing 3.1% to $5.5 billion. The company reports revenues from two segments: Pharmacy Business Management [PBM] and Emerging Markets (EM). PBM product revenue consists of revenues from the sale of prescription drugs by retail pharmacies in the company’s retail pharmacy networks and revenues from the dispensing of prescription drugs from the company’s home delivery and specialty pharmacies. EM product revenues consist of distribution of certain fertility drugs and revenues from drug distribution services. PBM revenues increased 3.5% to $5.3 billion with network pharmacy revenues increasing by 3.4% mainly due to higher claims volume that were partially offset by price ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/01/esrx-express-scripts-earnings-report-is-in-line-with-forecasts/19229/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

